UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Traffic Management for Heterogeneous Networks With Opportunistic Unlicensed Spectrum Sharing

IEEE transactions on wireless communications, 2017-09, Vol.16 (9), p.5717-5731

2017

Volltextzugriff (PDF)

Cerebrospinal fluid soluble programmed death‐ligand 1 is a useful prognostic biomarker in primary central nervous system lymphoma

British journal of haematology, 2023-04, Vol.201 (1), p.75-85

2023

Volltextzugriff (PDF)

Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax

Annals of hematology, 2020-03, Vol.99 (3), p.501-511

2020

Volltextzugriff (PDF)

Immune signatures of bone marrow cells can independently predict prognosis in patients with myelodysplastic syndrome

British journal of haematology, 2022-01, Vol.196 (1), p.156-168

2022

Volltextzugriff (PDF)

TP53 status and impact on AML prognosis within the ELN 2022 risk classification

Blood, 2023-12, Vol.142 (23), p.2029-2033

2023

Volltextzugriff (PDF)

Effect of mutation allele frequency on the risk stratification of myelodysplastic syndrome patients

American journal of hematology, 2022-12, Vol.97 (12), p.1589-1598

2022

Volltextzugriff (PDF)

The expression levels of long non‐coding RNA KIAA0125 are associated with distinct clinical and biological features in myelodysplastic syndromes

British journal of haematology, 2021-02, Vol.192 (3), p.589-598

2021

Volltextzugriff (PDF)

Clinico‐genetic and prognostic analyses of 716 patients with primary myelodysplastic syndrome and myelodysplastic syndrome/acute myeloid leukemia based on the 2022 International Consensus Classification

American journal of hematology, 2023-03, Vol.98 (3), p.398-407

2023

Volltextzugriff (PDF)

DRC Violation Prediction After Global Route Through Convolutional Neural Network

IEEE transactions on very large scale integration (VLSI) systems, 2023-09, Vol.31 (9), p.1425-1438

2023

Volltextzugriff (PDF)

Optic neuropathy after chimeric antigen receptor T-cell therapy

Journal of the Formosan Medical Association, 2022-05, Vol.121 (5), p.1012-1013

2022

Volltextzugriff (PDF)

Long‐term outcomes of combined intravitreal methotrexate and systemic high‐dose methotrexate therapy in vitreoretinal lymphoma

Cancer medicine (Malden, MA), 2023-04, Vol.12 (7), p.8102-8111

2023

Volltextzugriff (PDF)

Stellae-123 gene expression signature improved risk stratification in Taiwanese acute myeloid leukemia patients

Scientific reports, 2024-05, Vol.14 (1), p.11064-11, Article 11064

2024

Volltextzugriff (PDF)

Generating Routing-Driven Power Distribution Networks With Machine-Learning Technique

IEEE transactions on computer-aided design of integrated circuits and systems, 2017-08, Vol.36 (8), p.1237-1250

2017

Volltextzugriff (PDF)

Distinct clinical and biological characteristics of acute myeloid leukemia with higher expression of long noncoding RNA KIAA0125

Annals of hematology, 2021-02, Vol.100 (2), p.487-498

2021

Volltextzugriff (PDF)

Adoptive donor immunity protects against resolved hepatitis B virus reactivation after allogeneic haematopoietic stem cell transplantation in the world's largest retrospective cohort study

British journal of haematology, 2019-07, Vol.186 (1), p.72-85

2019

Volltextzugriff (PDF)

Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome

Blood cancer journal (New York), 2018-04, Vol.8 (4), p.39-13, Article 39

2018

Volltextzugriff (PDF)

Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor‐risk factor in de novo acute myeloid leukemia patients

European journal of haematology, 2018-07, Vol.101 (1), p.86-94

2018

Volltextzugriff (PDF)

Distinct genetic landscapes and their clinical implications in younger and older patients with myelodysplastic syndromes

Hematological oncology, 2023-08, Vol.41 (3), p.463-473

2023

Volltextzugriff (PDF)

Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA

Haematologica (Roma), 2018-11, Vol.103 (11), p.e510-e513

2018

Volltextzugriff (PDF)

Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission

Bone marrow transplantation (Basingstoke), 2022-01, Vol.57 (1), p.95-105

2022

Volltextzugriff (PDF)

Response to letter to the editor “Epidemiology and survival outcomes of acute myeloid leukemia patients in Taiwan: A national population-based analysis from 2001 to 2015”

Journal of the Formosan Medical Association, 2024-01, Vol.123 (1), p.137-137

2024

Volltextzugriff (PDF)

Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the phase 3 POLARIX trial

Blood, 2023-04, Vol.141 (16), p.1971-1981

2023

Volltextzugriff (PDF)

Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classification

Blood cancer journal (New York), 2023-08, Vol.13 (1), p.120-8, Article 120

2023

Volltextzugriff (PDF)

Brentuximab vedotin as a salvage treatment for relapsed and refractory Hodgkin lymphoma patients in Taiwan

Journal of the Formosan Medical Association, 2019-10, Vol.118 (10), p.1466-1470

2019

Volltextzugriff (PDF)

Higher RUNX1 expression levels are associated with worse overall and leukaemia‐free survival in myelodysplastic syndrome patients

EJHaem, 2022-11, Vol.3 (4), p.1209-1219

2022

Volltextzugriff (PDF)

1 – 25 von 341

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(289)
Mit Volltextzugriff
(305)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(210)
Life Sciences & Biomedicine
(122)
Humans
(72)
Technology
(68)
Physical Sciences
(46)
Male
(38)
Materials Science
(35)
Hematology
(34)
Prognosis
(33)
Aged
(30)
Oncology
(30)
Chemistry
(29)
Female
(29)
Middle Aged
(27)
Engineering
(25)
Mutation
(25)
Aged, 80 And Over
(22)
Biological And Medical Sciences
(22)
Engineering, Electrical & Electronic
(21)
Medical Sciences
(20)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Traffic Management for Heterogeneous Networks With Opportunistic Unlicensed Spectrum Sharing

Cerebrospinal fluid soluble programmed death‐ligand 1 is a useful prognostic biomarker in primary central nervous system lymphoma

Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax

Immune signatures of bone marrow cells can independently predict prognosis in patients with myelodysplastic syndrome

TP53 status and impact on AML prognosis within the ELN 2022 risk classification

Effect of mutation allele frequency on the risk stratification of myelodysplastic syndrome patients

The expression levels of long non‐coding RNA KIAA0125 are associated with distinct clinical and biological features in myelodysplastic syndromes

Clinico‐genetic and prognostic analyses of 716 patients with primary myelodysplastic syndrome and myelodysplastic syndrome/acute myeloid leukemia based on the 2022 International Consensus Classification

DRC Violation Prediction After Global Route Through Convolutional Neural Network

Optic neuropathy after chimeric antigen receptor T-cell therapy

Long‐term outcomes of combined intravitreal methotrexate and systemic high‐dose methotrexate therapy in vitreoretinal lymphoma

Stellae-123 gene expression signature improved risk stratification in Taiwanese acute myeloid leukemia patients

Generating Routing-Driven Power Distribution Networks With Machine-Learning Technique

Distinct clinical and biological characteristics of acute myeloid leukemia with higher expression of long noncoding RNA KIAA0125

Adoptive donor immunity protects against resolved hepatitis B virus reactivation after allogeneic haematopoietic stem cell transplantation in the world's largest retrospective cohort study

Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome

Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor‐risk factor in de novo acute myeloid leukemia patients

Distinct genetic landscapes and their clinical implications in younger and older patients with myelodysplastic syndromes

Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA

Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission

Response to letter to the editor “Epidemiology and survival outcomes of acute myeloid leukemia patients in Taiwan: A national population-based analysis from 2001 to 2015”

Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the phase 3 POLARIX trial

Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classification

Brentuximab vedotin as a salvage treatment for relapsed and refractory Hodgkin lymphoma patients in Taiwan

Higher RUNX1 expression levels are associated with worse overall and leukaemia‐free survival in myelodysplastic syndrome patients

Suchergebnisse filtern